Finance

Lists
TTI:CVE
Thiogenesis Therapeutics Corp
0,51 CAD
+2,00%
(+0,0100) 1D
19-окт., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for TTI...
Open
0,53 CAD
High
0,53 CAD
Low
0,51 CAD
Mkt. cap
35,69 млн
Avg. vol.
46,63 миң
Volume
4,50 миң
52-wk high
0,81 CAD
52-wk low
0,44 CAD
EPS
-0,12 CAD
Beta
0,44
Shares outstanding
69,98 млн
Open
0,53 CAD
High
0,53 CAD
Low
0,51 CAD
Mkt. cap
35,69 млн
Avg. vol.
46,63 миң
Volume
4,50 миң
52-wk high
0,81 CAD
52-wk low
0,44 CAD
EPS
-0,12 CAD
Beta
0,44
Shares outstanding
69,98 млн
News stories
From web sources and news partners
About Thiogenesis Therapeutics Corp
CEO-
Employees-
Founded2018
HeadquartersТоронто, Онтарио, Канада
Sector-
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,92 млн
1,27 млн
579,55 миң
1,24 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
471,84 миң
464,40 миң
338,28 миң
242,34 миң
Operating expense
2,39 млн
1,73 млн
917,82 миң
1,48 млн
Total operating expenses
2,39 млн
1,73 млн
917,82 миң
1,48 млн
Operating income
-2,39 млн
-1,73 млн
-917,82 миң
-1,48 млн
Other non operating income
-
-
-
-
EBT including unusual items
-2,38 млн
-1,73 млн
-911,82 миң
-1,49 млн
EBT excluding unusual items
-2,38 млн
-1,73 млн
-911,82 миң
-1,49 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,38 млн
-1,73 млн
-911,82 миң
-1,49 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
6,45 миң
4,42 миң
51,00
2,18 миң
Interest expense
-
-
-
-
Net interest expenses
6,45 миң
4,42 миң
51,00
2,18 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору